Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;62(2):294-304.
doi: 10.1111/j.1365-2559.2012.04355.x. Epub 2012 Sep 28.

β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis

Sebastian Huss  1 , Julia Nehles, Elke Binot, Eva Wardelmann, Jens Mittler, Michaela Angelika Kleine, Helen Künstlinger, Wolfgang Hartmann, Peter Hohenberger, Sabine Merkelbach-Bruse, Reinhard Buettner, Hans-Ulrich Schildhaus
Affiliations

β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis

Sebastian Huss et al. Histopathology. 2013 Jan.

Abstract

Aims and methods: Desmoid-type fibromatosis (desmoid) is a fibroblastic tumour that shows locally aggressive growth. Mesenteric desmoid is a rare lesion that shares morphological and biological features with fibromatoses occurring in the abdominal wall or in extraabdominal sites, but differs in terms of gross appearance and clinical presentation. We report on a series of 56 cases of mesenteric desmoids from our consultation files and compare them with cases of non-mesenteric desmoids and retroperitoneal fibrosis.

Results: Primary diagnosis of desmoid-type fibromatosis was correct in 42%, and gastrointestinal stromal tumour was a common misdiagnosis. Nuclear expression of β-catenin was detected in 91.6% of all desmoids. Mutational analysis of exon 3 of the β-catenin gene (CTNNB1) revealed that mesenteric desmoids carried mutations significantly more often (51/56, 91.1%) than non-mesenteric tumours (20/28; 71.4%; P = 0.027). p.T41A occurred significantly more frequently in mesenteric fibromatoses (80.4%) than in abdominal wall and extra-abdominal fibromatoses (46.4%; P = 0.002). Two novel mutations (p.S45C and p.D32G) were found. In retroperitoneal fibrosis, mutations and nuclear β-catenin expression were absent. β-Catenin-negative desmoids either carried a CTNNB1 mutation or were associated with Gardner syndrome.

Conclusions: Our study provides evidence that some clinical and genetic features of mesenteric desmoids differ from those of non-mesenteric fibromatosis, and corroborates the usefulness of mutational analysis, especially in diagnosing β-catenin-negative mesenteric desmoids.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources